Collagen is the world's most abundant structural protein. It also has one of the worst amino acid profiles in sports nutrition, registering a DIAAS score of effectively zero. Yet it may be the most underrated recovery supplement in an athlete's stack. Resolving this apparent contradiction requires understanding that muscles and tendons do not use the same anabolic pathway — and conflating the two is one of the most common errors in evidence-based sports nutrition.
If your goal is to build muscle, the DIAAS score matters enormously. If your goal is to maintain and adapt connective tissue, it becomes largely irrelevant.
---
The DIAAS (Digestible Indispensable Amino Acid Score) measures protein quality based on how well a protein supplies each of the essential amino acids relative to human reference requirements, corrected for true ileal digestibility. Collagen's DIAAS approaches zero because it contains no detectable leucine — the critical trigger amino acid for the mTORC1-p70S6K signalling cascade that initiates muscle protein synthesis (MPS).
The MPS pathway requires leucine to cross the blood threshold of approximately 2–3g per serving to activate mTORC1 and drive myofibrillar protein accretion. Collagen provides glycine, proline, and hydroxyproline in abundance — none of which cross this threshold or substitute for leucine in the mTORC1 pathway. Supplementing with collagen as a protein source for muscle building would be physiologically analogous to trying to build a brick wall with mortar and no bricks.
---
Tendons, however, operate on an entirely different anabolic logic. Tendon extracellular matrix is composed of approximately 90% Type I collagen — the exact structural form found in most collagen peptide supplements. The process of tendon remodelling and adaptation uses what researchers distinguish as collagen protein synthesis (CPS): a pathway driven by tenocyte (tendon cell) activity that incorporates hydroxyproline-proline sequences into collagen fibrils. Leucine is not required as a trigger for this process. Glycine and proline — abundantly present in collagen supplements — are the direct substrates.
Oikawa and colleagues (2019, Journal of Physiology) provided direct human evidence: recreational athletes supplementing with 15g of collagen peptides per day over 6 months showed significantly elevated patellar tendon collagen synthesis measured by stable isotope tracer methodology — the gold standard for in vivo protein synthesis measurement. This was tendon-specific; muscle MPS markers were not elevated by the collagen intervention.
---
Tendon biology has a feature that makes this particularly important to understand: turnover rate. Muscle protein has a half-life of roughly 1–2 days — it is continuously broken down and rebuilt, making it acutely responsive to each training session and each protein feeding. Mature mid-substance tendon collagen turns over at approximately 2–3% per year. Tendons respond to cumulative, sustained loading and supplementation signals over months — not to acute post-exercise protein spikes.
This biological timescale means that short-term collagen supplementation studies (2–4 weeks) frequently show no measureable effect — not because collagen doesn't work, but because the measurement window is too short. The clinical evidence base supports 3–6 month supplementation protocols for tendon remodelling outcomes, which is consistent with tendon biology but inconsistent with how most athletes approach supplementation decisions.
Collagen degradation can be tracked via urine markers: CTX-II (C-terminal crosslinking telopeptide of collagen type II) and hydroxyproline excretion reflect connective tissue remodelling activity over time. These biomarkers provide a slow but measurable window into whether supplementation and training load are producing tendon adaptation or simply passing through.
---
The practical strategy that emerges from this evidence is a dual-pathway protocol: take collagen peptides (10–15g) with 50–100mg of vitamin C, approximately 60 minutes before training, to prime tendon collagen synthesis during the subsequent mechanical loading window. Post-training, take your whey protein or EAA blend to trigger muscle MPS. These are additive pathways — different tissues, different substrates, non-competitive.
Athletes managing patellar, Achilles, or rotator cuff tendinopathy alongside physical therapy represent the strongest evidence-based use case. The enthesis zone — the bone-tendon insertion point — and fibrocartilage transition zone are the regions most commonly involved in overuse pathology, and both respond to the combination of appropriate mechanical stimulus and connective tissue nutritional support.
For athletes who want to calculate their personalised collagen dosing protocol based on body weight and training frequency, the free tool at winsport.uk/tools/nutrition/collagen-dosage-joints provides evidence-based dose guidance for joint and connective tissue support.
The question worth asking: are you applying the same nutritional intentionality to your tendons as you do to your muscles — or treating them as passive passengers in your training?